
Manmohan Khanna
About Manmohan Khanna
Data last updated:
Manmohan Khanna is a Director at Beta Drugs Limited (since 2017). The company operates in Pharma. Beta Drugs Limited reported revenue of ₹369 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 26 Jul 2017 | 2005 | ₹369 Cr (FY 2025) | Active |
Board colleagues of Manmohan Khanna
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ajay Mahipal | 06949940 | Beta Drugs Limited | Director |
| Ashutosh Shukla | 09461568 | Beta Drugs Limited | Whole-Time Director |
| Balwant Singh | 01089968 | Beta Drugs Limited | Whole-Time Director |
| Lalit Kumar Watts | 10906518 | Beta Drugs Limited | Director |
| Monica Jain | 05253864 | Beta Drugs Limited | Director |
| Nipun Arora | Beta Drugs Limited | Cfo | |
| Rahul Batra | 02229234 | Beta Drugs Limited | Managing Director |
| Rajni Brar | Beta Drugs Limited | Company Secretary | |
| Rohit Parti | 07889944 | Beta Drugs Limited | Director |
| Sanjay Sehgal | 01235531 | Beta Drugs Limited | Director |
| Varun Batra | 02148383 | Beta Drugs Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manmohan Khanna
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manmohan Khanna
Manmohan Khanna currently holds 1 directorship: Beta Drugs Limited (Director, since 26 Jul 2017, revenue ₹369 Cr (FY 2025)).
Manmohan Khanna was first appointed on 26 Jul 2017 as Director at Beta Drugs Limited.
The current boards of Manmohan Khanna's companies include Ajay Mahipal (Beta Drugs Limited), Ashutosh Shukla (Beta Drugs Limited), Balwant Singh (Beta Drugs Limited), Lalit Kumar Watts (Beta Drugs Limited), Monica Jain (Beta Drugs Limited), Nipun Arora (Beta Drugs Limited), among others.